MARKET

CRMD

CRMD

Cormedix
NASDAQ
12.53
+0.34
+2.79%
After Hours: 12.50 -0.03 -0.23% 18:43 12/26 EST
OPEN
12.20
PREV CLOSE
12.19
HIGH
12.61
LOW
12.07
VOLUME
1.95M
TURNOVER
--
52 WEEK HIGH
17.43
52 WEEK LOW
5.60
MARKET CAP
987.23M
P/E (TTM)
6.10
1D
5D
1M
3M
1Y
5Y
1D
Can CorMedix's Melinta Acquisition Aid Growth Beyond DefenCath?
NASDAQ · 1d ago
FDA Issues CRL to SNY's Regulatory Filing for Multiple Sclerosis Drug
NASDAQ · 3d ago
AGIO's Mitapivat Gets FDA Nod for Thalassemia Indication with REMS in Label
NASDAQ · 3d ago
Sanofi to Buy Dynavax for $2.2B to Boost Adult Vaccine Franchise
NASDAQ · 3d ago
GILD Exercises Option to License Assembly Bio's Herpes Programs
NASDAQ · 4d ago
CRSP Stock Rises on Encouraging Early Data From Zugo-Cel Studies
NASDAQ · 4d ago
JNJ's Tremfya Gets EU Approval for Pediatric Plaque Psoriasis
NASDAQ · 4d ago
AZN, Daiichi's Enhertu Gets FDA Nod for First-Line Breast Cancer (Revised)
NASDAQ · 4d ago
More
About CRMD
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product, DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 milligrams per milliliter (mg/mL), and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). The Company is also commercializing a portfolio of anti-infective products including MINOCIN, REZZAYO, VABOMERE, ORBACTIV, BAXDELA, and KIMYRSA, as well as TOPROL-XL.

Webull offers CorMedix Inc stock information, including NASDAQ: CRMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRMD stock methods without spending real money on the virtual paper trading platform.